OI Suite

Drug discovery and biotech · by Imagene AI

A SaaS enterprise solution for AI-driven oncology research, including hypothesis generation, biomarker discovery, response prediction, and model training with limited data.

What it does

A SaaS enterprise solution for AI-driven oncology research, including hypothesis generation, biomarker discovery, response prediction, and model training with limited data. At its core is the Oncology Intelligence Foundation Model (CanvOI), a scalable, generalizable, and versatile backbone for diverse oncology applications.

  • AI-driven hypothesis generation for oncology research
  • Biomarker discovery
  • Drug development and clinical trial acceleration
  • Response prediction and prognosis assessment
  • Pathological feature identification with limited data
Category
Drug discovery and biotech
Built for
Healthcare and life sciences
Users
Translational research teams, Drug discovery and development organizations, Clinical trial teams, Oncology researchers
Public API
Not offered
Deployment
On-premises

Not yet disclosed: platforms, languages and support channels.

Pricing

  • Free plan$0

Prices as published by Imagene AI, checked Oct 2026.

Security and compliance

No security details published yet

Imagene AI hasn't published certifications or security practices for OI Suite that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use OI Suite at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim OI Suite